1. Home
  2. NMRA vs NECB Comparison

NMRA vs NECB Comparison

Compare NMRA & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • NECB
  • Stock Information
  • Founded
  • NMRA 2019
  • NECB 1934
  • Country
  • NMRA United States
  • NECB United States
  • Employees
  • NMRA N/A
  • NECB N/A
  • Industry
  • NMRA
  • NECB Savings Institutions
  • Sector
  • NMRA
  • NECB Finance
  • Exchange
  • NMRA Nasdaq
  • NECB Nasdaq
  • Market Cap
  • NMRA 287.6M
  • NECB 295.3M
  • IPO Year
  • NMRA 2023
  • NECB N/A
  • Fundamental
  • Price
  • NMRA $1.28
  • NECB $22.82
  • Analyst Decision
  • NMRA Buy
  • NECB
  • Analyst Count
  • NMRA 8
  • NECB 0
  • Target Price
  • NMRA $10.14
  • NECB N/A
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • NECB 50.3K
  • Earning Date
  • NMRA 03-03-2025
  • NECB 04-24-2025
  • Dividend Yield
  • NMRA N/A
  • NECB 2.86%
  • EPS Growth
  • NMRA N/A
  • NECB 7.83
  • EPS
  • NMRA N/A
  • NECB 3.52
  • Revenue
  • NMRA N/A
  • NECB $104,835,000.00
  • Revenue This Year
  • NMRA N/A
  • NECB $1.50
  • Revenue Next Year
  • NMRA N/A
  • NECB $8.02
  • P/E Ratio
  • NMRA N/A
  • NECB $6.47
  • Revenue Growth
  • NMRA N/A
  • NECB 6.02
  • 52 Week Low
  • NMRA $1.26
  • NECB $14.77
  • 52 Week High
  • NMRA $17.19
  • NECB $31.72
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.96
  • NECB 43.68
  • Support Level
  • NMRA $1.26
  • NECB $21.31
  • Resistance Level
  • NMRA $1.48
  • NECB $23.10
  • Average True Range (ATR)
  • NMRA 0.13
  • NECB 0.63
  • MACD
  • NMRA 0.08
  • NECB 0.03
  • Stochastic Oscillator
  • NMRA 4.44
  • NECB 60.64

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. They conduct their activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

Share on Social Networks: